Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

TechnologyAdvice

- PMLiVE

Bayer sues Glenmark over its skin disorder generic

India-based firm files for US approval of its version of Finacea

- PMLiVE

PMGroup makes senior appointments

Clare Bates moves to commercial director and Dominic Tyer becomes editorial director

- PMLiVE

Merck & Co’s sugammadex delayed in US

FDA says it needs more time to review application

- PMLiVE

Dr Reddy’s Laboratories founder passes away

Dr K. Anji Reddy loses cancer battle

- PMLiVE

FDA investigates pancreas risk of diabetes drugs

Products from Merck & Co, BMS, AZ, Novo Nordisk, Boehringer, Amylin and Takeda all involved

- PMLiVE

How robust is your targeting?

Should we be targeting customers on what they have done in the past, or what they think they will do in the future?

- PMLiVE

Ex-Pfizer executive Ed Mascioli joins Affinium as CEO

Robert Radie also appointed to board of directors

Digital: Everyone has to keep learning

In a guest blog, Faisal Ahmed says that when it comes to digital we all have to learn and keep on learning

- PMLiVE

Ogilvy Brussels names new associate director

Barbara Malengreaux will lead the consumer and health practice

Novartis building

FDA deems Novartis lung cancer drug a “breakthrough therapy”

LDK378 will have accelerated passage through development

- PMLiVE

Vanda withdraws EU application for schizophrenia drug

CHMP had previously refused to back the approval of Fanaptum

- PMLiVE

FDA explains draft Alzheimer’s guidance in NEJM editorial

Intends to relax requirements in patient function and cognition

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links